Search
forResearch 10 of 1000+
- 41261 Identification of Demographic and Clinical Features Associated with Multi-Biologic Failure in the CorEvitas Psoriasis Registry
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Adverse Effects and Drug Interactions of Biologic Agents
- Paradoxical reactions in the era of modern biological therapy of psoriasis — a comprehensive analysis of pathomechanisms and clinical guidelines
- ZAOSTRZENIA NIEWYDOLNOŚCI ODDECHOWEJ- PRZYCZYNY I POSTĘPOWANIE
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- ADRENAL FAILURE: WHEN ANTIPHOSPHOLIPID SYNDROME LEAVES SCARS
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
Community 2 of 4
- Why hasn’t anyone made a "DHT sponge" biologic yet???
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
Learn
— no results
Try a deeper search in learn →